...aromatase inhibitor fadrozole be useful for clinical investigation of aldosteronesynthase inhibition? Journal of Hypertension 24 993–997.
(doi:10.1097/01.hjh.0000226183.98439.b3) Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS,
Mullins JJ & Seckl JR 2004 Novel ~~~